Global Naldemedine Market Growth 2022-2028
- LP 4768519
- 71 Pages
- January 2022
- Pharmaceuticals
The United States Naldemedine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Naldemedine market, reaching US$ million by the year 2028. As for the Europe Naldemedine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Naldemedine players cover Shionogi, Purdue Pharma, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Naldemedine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Self-production API
Outsourcing of API
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Drug Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Shionogi
Purdue Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Naldemedine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Naldemedine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Naldemedine by Country/Region, 2017, 2022 & 2028
2.2 Naldemedine Segment by Type
2.2.1 Self-production API
2.2.2 Outsourcing of API
2.3 Naldemedine Sales by Type
2.3.1 Global Naldemedine Sales Market Share by Type (2017-2022)
2.3.2 Global Naldemedine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Naldemedine Sale Price by Type (2017-2022)
2.4 Naldemedine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drug Center
2.4.4 Other
2.5 Naldemedine Sales by Application
2.5.1 Global Naldemedine Sale Market Share by Application (2017-2022)
2.5.2 Global Naldemedine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Naldemedine Sale Price by Application (2017-2022)
3 Global Naldemedine by Company
3.1 Global Naldemedine Breakdown Data by Company
3.1.1 Global Naldemedine Annual Sales by Company (2020-2022)
3.1.2 Global Naldemedine Sales Market Share by Company (2020-2022)
3.2 Global Naldemedine Annual Revenue by Company (2020-2022)
3.2.1 Global Naldemedine Revenue by Company (2020-2022)
3.2.2 Global Naldemedine Revenue Market Share by Company (2020-2022)
3.3 Global Naldemedine Sale Price by Company
3.4 Key Manufacturers Naldemedine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Naldemedine Product Location Distribution
3.4.2 Players Naldemedine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Naldemedine by Geographic Region
4.1 World Historic Naldemedine Market Size by Geographic Region (2017-2022)
4.1.1 Global Naldemedine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Naldemedine Annual Revenue by Geographic Region
4.2 World Historic Naldemedine Market Size by Country/Region (2017-2022)
4.2.1 Global Naldemedine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Naldemedine Annual Revenue by Country/Region
4.3 Americas Naldemedine Sales Growth
4.4 APAC Naldemedine Sales Growth
4.5 Europe Naldemedine Sales Growth
4.6 Middle East & Africa Naldemedine Sales Growth
5 Americas
5.1 Americas Naldemedine Sales by Country
5.1.1 Americas Naldemedine Sales by Country (2017-2022)
5.1.2 Americas Naldemedine Revenue by Country (2017-2022)
5.2 Americas Naldemedine Sales by Type
5.3 Americas Naldemedine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Naldemedine Sales by Region
6.1.1 APAC Naldemedine Sales by Region (2017-2022)
6.1.2 APAC Naldemedine Revenue by Region (2017-2022)
6.2 APAC Naldemedine Sales by Type
6.3 APAC Naldemedine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Naldemedine by Country
7.1.1 Europe Naldemedine Sales by Country (2017-2022)
7.1.2 Europe Naldemedine Revenue by Country (2017-2022)
7.2 Europe Naldemedine Sales by Type
7.3 Europe Naldemedine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Naldemedine by Country
8.1.1 Middle East & Africa Naldemedine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Naldemedine Revenue by Country (2017-2022)
8.2 Middle East & Africa Naldemedine Sales by Type
8.3 Middle East & Africa Naldemedine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Naldemedine
10.3 Manufacturing Process Analysis of Naldemedine
10.4 Industry Chain Structure of Naldemedine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Naldemedine Distributors
11.3 Naldemedine Customer
12 World Forecast Review for Naldemedine by Geographic Region
12.1 Global Naldemedine Market Size Forecast by Region
12.1.1 Global Naldemedine Forecast by Region (2023-2028)
12.1.2 Global Naldemedine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Naldemedine Forecast by Type
12.7 Global Naldemedine Forecast by Application
13 Key Players Analysis
13.1 Shionogi
13.1.1 Shionogi Company Information
13.1.2 Shionogi Naldemedine Product Offered
13.1.3 Shionogi Naldemedine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shionogi Main Business Overview
13.1.5 Shionogi Latest Developments
14 Research Findings and Conclusion
Table 1. Naldemedine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Naldemedine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Self-production API
Table 4. Major Players of Outsourcing of API
Table 5. Global Naldemedine Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Naldemedine Sales Market Share by Type (2017-2022)
Table 7. Global Naldemedine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Naldemedine Revenue Market Share by Type (2017-2022)
Table 9. Global Naldemedine Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Naldemedine Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Naldemedine Sales Market Share by Application (2017-2022)
Table 12. Global Naldemedine Revenue by Application (2017-2022)
Table 13. Global Naldemedine Revenue Market Share by Application (2017-2022)
Table 14. Global Naldemedine Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Naldemedine Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Naldemedine Sales Market Share by Company (2020-2022)
Table 17. Global Naldemedine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Naldemedine Revenue Market Share by Company (2020-2022)
Table 19. Global Naldemedine Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Naldemedine Producing Area Distribution and Sales Area
Table 21. Players Naldemedine Products Offered
Table 22. Naldemedine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Naldemedine Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Naldemedine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Naldemedine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Naldemedine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Naldemedine Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Naldemedine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Naldemedine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Naldemedine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Naldemedine Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Naldemedine Sales Market Share by Country (2017-2022)
Table 35. Americas Naldemedine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Naldemedine Revenue Market Share by Country (2017-2022)
Table 37. Americas Naldemedine Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Naldemedine Sales Market Share by Type (2017-2022)
Table 39. Americas Naldemedine Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Naldemedine Sales Market Share by Application (2017-2022)
Table 41. APAC Naldemedine Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Naldemedine Sales Market Share by Region (2017-2022)
Table 43. APAC Naldemedine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Naldemedine Revenue Market Share by Region (2017-2022)
Table 45. APAC Naldemedine Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Naldemedine Sales Market Share by Type (2017-2022)
Table 47. APAC Naldemedine Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Naldemedine Sales Market Share by Application (2017-2022)
Table 49. Europe Naldemedine Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Naldemedine Sales Market Share by Country (2017-2022)
Table 51. Europe Naldemedine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Naldemedine Revenue Market Share by Country (2017-2022)
Table 53. Europe Naldemedine Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Naldemedine Sales Market Share by Type (2017-2022)
Table 55. Europe Naldemedine Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Naldemedine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Naldemedine Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Naldemedine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Naldemedine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Naldemedine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Naldemedine Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Naldemedine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Naldemedine Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Naldemedine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Naldemedine
Table 66. Key Market Challenges & Risks of Naldemedine
Table 67. Key Industry Trends of Naldemedine
Table 68. Naldemedine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Naldemedine Distributors List
Table 71. Naldemedine Customer List
Table 72. Global Naldemedine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Naldemedine Sales Market Forecast by Region
Table 74. Global Naldemedine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Naldemedine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Naldemedine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Naldemedine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Naldemedine Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Naldemedine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Naldemedine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Naldemedine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Naldemedine Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Naldemedine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Naldemedine Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Naldemedine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Naldemedine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Naldemedine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Naldemedine Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Naldemedine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Naldemedine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Naldemedine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Shionogi Basic Information, Naldemedine Manufacturing Base, Sales Area and Its Competitors
Table 93. Shionogi Naldemedine Product Offered
Table 94. Shionogi Naldemedine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Shionogi Main Business
Table 96. Shionogi Latest Developments
Table 97. Purdue Pharma Basic Information, Naldemedine Manufacturing Base, Sales Area and Its Competitors
Table 98. Purdue Pharma Naldemedine Product Offered
Table 99. Purdue Pharma Naldemedine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Purdue Pharma Main Business
Table 101. Purdue Pharma Latest Developments
List of Figures
Figure 1. Picture of Naldemedine
Figure 2. Naldemedine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Naldemedine Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Naldemedine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Naldemedine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Self-production API
Figure 10. Product Picture of Outsourcing of API
Figure 11. Global Naldemedine Sales Market Share by Type in 2021
Figure 12. Global Naldemedine Revenue Market Share by Type (2017-2022)
Figure 13. Naldemedine Consumed in Hospital
Figure 14. Global Naldemedine Market: Hospital (2017-2022) & (K Pcs)
Figure 15. Naldemedine Consumed in Clinic
Figure 16. Global Naldemedine Market: Clinic (2017-2022) & (K Pcs)
Figure 17. Naldemedine Consumed in Drug Center
Figure 18. Global Naldemedine Market: Drug Center (2017-2022) & (K Pcs)
Figure 19. Naldemedine Consumed in Other
Figure 20. Global Naldemedine Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Naldemedine Sales Market Share by Application (2017-2022)
Figure 22. Global Naldemedine Revenue Market Share by Application in 2021
Figure 23. Naldemedine Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Naldemedine Revenue Market Share by Company in 2021
Figure 25. Global Naldemedine Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Naldemedine Revenue Market Share by Geographic Region in 2021
Figure 27. Global Naldemedine Sales Market Share by Region (2017-2022)
Figure 28. Global Naldemedine Revenue Market Share by Country/Region in 2021
Figure 29. Americas Naldemedine Sales 2017-2022 (K Pcs)
Figure 30. Americas Naldemedine Revenue 2017-2022 ($ Millions)
Figure 31. APAC Naldemedine Sales 2017-2022 (K Pcs)
Figure 32. APAC Naldemedine Revenue 2017-2022 ($ Millions)
Figure 33. Europe Naldemedine Sales 2017-2022 (K Pcs)
Figure 34. Europe Naldemedine Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Naldemedine Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Naldemedine Revenue 2017-2022 ($ Millions)
Figure 37. Americas Naldemedine Sales Market Share by Country in 2021
Figure 38. Americas Naldemedine Revenue Market Share by Country in 2021
Figure 39. United States Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Naldemedine Sales Market Share by Region in 2021
Figure 44. APAC Naldemedine Revenue Market Share by Regions in 2021
Figure 45. China Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Naldemedine Sales Market Share by Country in 2021
Figure 52. Europe Naldemedine Revenue Market Share by Country in 2021
Figure 53. Germany Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Naldemedine Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Naldemedine Revenue Market Share by Country in 2021
Figure 60. Egypt Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Naldemedine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Naldemedine in 2021
Figure 66. Manufacturing Process Analysis of Naldemedine
Figure 67. Industry Chain Structure of Naldemedine
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
